• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 21, 2021
Targets & Mechanisms

Next-generation multiple sclerosis therapies look beyond B cells 

Early-stage approaches aim for more precise immune suppression, remyelination
Read More
BioCentury | Mar 19, 2019
Distillery Therapeutics

Inhibiting SATB1 in Th17 cells for multiple sclerosis

Read More
BioCentury | Mar 1, 2019
Translation in Brief

Targeting pathogenic Th17 cells

How two new autoimmune targets drive pathogenic Th17 activity
Read More
BioCentury | Apr 10, 2008
Cover Story

Metastasis, Interrupted

Read More
BioCentury | Mar 27, 2008
Distillery Therapeutics

This Week in Therapeutics

Read More
Items per page:
1 - 5 of 5